Home/Filings/4/0001104659-13-089469
4//SEC Filing

Cyclacel Pharmaceuticals, Inc. 4

Accession 0001104659-13-089469

$BGMSCIK 0001130166operating

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 5:23 PM ET

Size

5.5 KB

Accession

0001104659-13-089469

Insider Transaction Report

Form 4
Period: 2013-12-09
Chiao Judy
V.P., Clin. Dev. & Reg. Aff.
Transactions
  • Award

    Option

    2013-12-09+65,00065,000 total
    Exercise: $4.61Exp: 2023-12-09Common Stock (65,000 underlying)
Footnotes (2)
  • [F1]These options are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
  • [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.

Documents

1 file

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001130166

Filing Metadata

Form type
4
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:23 PM ET
Size
5.5 KB